Raymond James Trust N.A. Acquires 1,442 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Raymond James Trust N.A. raised its position in HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 6.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,747 shares of the company’s stock after acquiring an additional 1,442 shares during the quarter. Raymond James Trust N.A.’s holdings in HCA Healthcare were worth $4,159,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in HCA. Baltimore Washington Financial Advisors Inc. acquired a new stake in shares of HCA Healthcare during the 4th quarter worth about $26,000. GoalVest Advisory LLC acquired a new stake in HCA Healthcare in the 1st quarter worth about $26,000. Wolff Wiese Magana LLC raised its stake in HCA Healthcare by 1,833.3% in the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock worth $29,000 after purchasing an additional 110 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new stake in HCA Healthcare in the 1st quarter worth about $29,000. Finally, San Luis Wealth Advisors LLC acquired a new stake in HCA Healthcare in the 1st quarter worth about $35,000. Institutional investors and hedge funds own 65.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on HCA. Credit Suisse Group raised their target price on shares of HCA Healthcare from $230.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, July 25th. The Goldman Sachs Group decreased their target price on shares of HCA Healthcare from $270.00 to $233.00 and set a “buy” rating on the stock in a report on Tuesday, July 12th. SVB Leerink raised their target price on shares of HCA Healthcare from $240.00 to $259.00 and gave the company an “outperform” rating in a report on Wednesday, August 24th. Truist Financial lifted their price target on shares of HCA Healthcare from $208.00 to $240.00 and gave the company a “buy” rating in a report on Monday, July 25th. Finally, Royal Bank of Canada decreased their price target on shares of HCA Healthcare from $267.00 to $256.00 and set an “outperform” rating on the stock in a report on Tuesday, June 21st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $239.14.

Insider Transactions at HCA Healthcare

In related news, major shareholder Patricia F. Elcan purchased 325 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 25th. The stock was bought at an average price of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the transaction, the insider now owns 89,337 shares in the company, valued at $17,747,688.42. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Down 2.4 %

HCA Healthcare stock opened at $194.06 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.55 and a debt-to-equity ratio of 87.46. HCA Healthcare, Inc. has a 12-month low of $164.47 and a 12-month high of $279.02. The firm’s fifty day moving average is $205.76 and its 200 day moving average is $214.90. The company has a market capitalization of $55.70 billion, a PE ratio of 9.33, a PEG ratio of 1.51 and a beta of 1.72.

HCA Healthcare (NYSE:HCAGet Rating) last announced its quarterly earnings results on Friday, July 22nd. The company reported $4.21 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.54. The business had revenue of $14.82 billion during the quarter, compared to analyst estimates of $14.73 billion. HCA Healthcare had a net margin of 10.83% and a return on equity of 833.68%. HCA Healthcare’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.37 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 17.09 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be paid a dividend of $0.56 per share. The ex-dividend date of this dividend is Thursday, September 15th. This represents a $2.24 dividend on an annualized basis and a yield of 1.15%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.77%.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.